Equivocal (HER2 IHC 2+) breast carcinomas: gene–protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits
暂无分享,去创建一个
T. Tot | D. Hellberg | Gyula Pekar | Ionna Kasselaki | Á. Pekár-Lukacs | Csaba Dekany | G. Pekar | D. Hellberg, | Ágnes Pekár-Lukacs